Scope of the Study
The amniotic membrane is defined as the innermost layer of the placenta with a thickness of 0.02-0.05 mm. It is used in two categories namely the management of wounds as well as a biological bandage for the treatment. It is widely used in the treatment of various diseases such as eye surface disorders, corneal degeneration, ocular dystrophy, eyelid reconstruction, bacterial keratitis, corneal ulcers, cataract, glaucoma, bullous keratopathy, among others. Demand for amniotic membrane has increased, due to the rising number of non-communicable diseases patients. For instance, 1n 2018, as per an article published by the World Health Organization (WHO), non-communicable diseases, such as Cardiovascular Diseases chronic respiratory diseases, diabetes, as well as cancer together account for more than 86% of deaths and also it is found that more than 77% of the disease burden in the European region. Therefore, increasing the prevalence of chronic diseases will affect the growth of the market in the future.
The market study is being classified, by Application (Surgical Wounds, Ophthalmology and Others) and major geographies with country level break-up.
FzioMed, Inc. (United States), Skye Biologics Inc. (United States), IOP Ophthalmics (United States), Amniox Medical, Inc. (United States), Amnio Technology, LLC (United States), Applied Biologics LLC (United States), Alliqua BioMedical, Inc. (United States), Human Regenerative Technologies LLC (United States), Derma Sciences Inc. (United States) and MiMedx Group, Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Integra LifeSciences (United States) and Osiris Therapeutics, Inc. (United States).
Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Amniotic Membrane market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Amniotic Membrane market by Type, Application and Region.
On the basis of geography, the market of Amniotic Membrane has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Growing Research and Development Investments in the Field Of Stem Cell & Regenerative Medicine
- Increase in the Number of Surgeries Being Performed across the World
- Technology Advancements regarding Amniotic Membrane
- Stringent Rules as well as Regulation
- Government Initiative Regarding the Treatment of Diseases
- Growing Demand from Emerging Economics such as China, India, among others
- Lack of Awareness in Some Region
In February 2019, the Israeli doctors (Rambam Health Care Campus) has recently conducted a successful procedure. In this procedure, where a woman’s eyesight has been restored using the placenta. Hence, it will affect the growth of the market in the future.
Key Target AudienceAmniotic Membrane Companies, Research and Development (R&D) Companies, Research Organization, Federal Agencies and Others
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase